Goldman Scarlato & Penny, P.C. is pleased to announce that Melissa Fry Hague, Esquire has joined the firm as a partner. Melissa will lead the firm’s new Mass Tort litigation practice, and brings over ten years’ experience litigating cases involving dangerous drugs and defective medical devices. She currently serves on the Plaintiffs’ Steering Committee in In Re: Zofran (Ondansetron) Products Liability Litigation, and has successfully represented hundreds of plaintiffs injured by defective metal-on-metal hip implants, and knee implants. Melissa has also successfully represented victims who received infected and stolen cadaver bone in the In re: Human Tissue Products Liability Litigation, and has been a fierce advocate for women harmed by defective transvaginal mesh products and Fosamax. Melissa has earned a reputation as a diligent and zealous attorney among her peers, both locally and nationally.
Melissa’s passion for justice extends to her active involvement in the American Association for Justice where she currently serves as the Chair of the New Lawyers Division. Melissa earned her J.D. from Widener University School of Law in 2006, and is admitted to practice in Pennsylvania and New Jersey. Prior to joining Goldman Scarlato & Penny, P.C. Melissa was a partner at a premiere personal injury firm in Philadelphia.